This website is intended for healthcare professionals only.
Hospital Pharmacy Europe
Newsletter
Login
News
In depth
Views
Clinical
Cardiovascular
Dermatology
Emergency and critical care
Gastroenterology
Oncology
Paediatrics
Pathology and diagnostics
Radiology and imaging
Respiratory
Rheumatology
Insight and Analysis
Q&As
European healthcare data
Webinars
Country profiles
Events
Sponsored
Newsletter
Hospital Pharmacy Europe
Clinical
Celltrion’s biosimilar trastuzumab approved in Europe
Read more
NICE Final Appraisal Determination recommends use of brodalumab as cost-effective
Read more
NICE recommends tivozanib as first-line treatment for advanced renal cell carcinoma
Read more
Results of largest-ever trial for prevention of skeletal-related events in multiple myeloma published
Read more
Crash diets can cause transient deterioration in heart function
Read more
Rapid blood vessel scan tolerated by claustrophobic patients unable to stand longer tests
Read more
CHMP positive opinion to add updated overall survival data to carfilzomib label received
Read more
Republic of Ireland switches to extended half-life therapies for haemophilia A and B
Read more
CE marking of Eve™ CCHD Newborn Screening Application
Read more
Positive results of Phase III study of once-daily therapy in newly diagnosed focal epilepsy patients
Read more
Letermovir granted marketing authorisation as an orphan medicinal product
Read more
New study to help improve life for headache sufferers
Read more
Clinical utility of ORi™, Masimo Oxygen Reserve Index™ in obese patients
Read more
CE marking and release of Oxygen Reserve Index™ rainbow Lite sensors
Read more
New trial to improve lives of long-term painkiller users
Read more
Positive results in unique Phase IIIb LIBERTY study in episodic migraine patients
Read more
EC approves biosimilar bevacizumab for the treatment of certain types of cancer
Read more
Page 128 of 200
« First
«
...
10
20
30
...
126
127
128
129
130
...
140
150
160
...
»
Last »
Popular articles
Third of patients in favour of AI-supported consultations and clinical documents, study finds
18 April, 2024
Telemedicine strategy post-acute coronary syndrome drives efficiencies and safety, study finds
17 April, 2024
Bimekizumab gains EC approval for hidradenitis suppurativa
22 April, 2024
x
Search for: